| cryo EM structure of apo hMRP4 | | monomer | 1-1298 | |
| Assess |
| cryo-EM structure of ATP-bound hMRP4 | | monomer | 6-1301 | 2×ATP; 2×MG; |
| Assess |
| cryo-EM structure of sulindac-bound hMRP4 | | monomer | 5-1299 | 1×SUZ; |
| Assess |
| cryo-EM structure of PGE1-bound hMRP4 | | monomer | 7-1298 | 1×XPG; |
| Assess |
| Cryo-EM structure of dipyridamole-bound ABCC4 | | monomer | 9-1298 | 1×H9F; |
| Assess |
| Cryo-EM structure of ATP-U46619-bound ABCC4 | | monomer | 9-1298 | 2×ATP; 2×MG; 1×PUC; |
| Assess |
| Cryo-EM structure of apo-form ABCC4 | | monomer | 9-1298 | |
| Assess |
| Cryo-EM structure of aspirin-bound ABCC4 | | monomer | 9-1298 | 1×AIN; |
| Assess |
| Cryo-EM structure of U46619-bound ABCC4 | | monomer | 9-1298 | 1×PUC; |
| Assess |
| Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (inward-facing conformation) | | monomer | 7-1294 | 2×CLR; 4×Y01; |
| Assess |
| Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (in complex with topotecan) | | monomer | 7-1294 | 1×TTC; |
| Assess |
| Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (in complex with prostaglandin E2) | | monomer | 7-1294 | 1×P2E; |
| Assess |
| Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (in complex with methotrexate) | | monomer | 7-1294 | 1×MTX; |
| Assess |
| Cryo-EM structure of nanodisc-reconstituted human MRP4 with E1202Q mutation (outward-facing occlude… | | monomer | 7-1294 | 2×ATP; 2×MG; |
| Assess |